Shuttle Pharmaceuticals Holdings, Inc
Price
FilingsNewest: 10-Q, Quarterly reportSep 24 →InsidersNo open-market buys or sales.→HoldersCitadel 2.4%Barclays 0.1%Tower Research Capital LLC (TRC) 0.0%→Financing →PeersClosest companies: SDEV, FFR, BNTC→
From the filings
Figures
- Net income
- −$10.3Mlast 12 months
- Operating cash flow
- −$9.4Mlast 12 months
- Cash and equivalents
- $90,238at the last balance sheet
- Shares outstanding
- 1.0M shareson issue